Callanga, Jerlyn R.
HRN: 08-39-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/26/2023
IV
2 G
Q24
Preseptal Cellitis; T/C Periodontal Abscess Left
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & MouthDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes